title: Fetopathy probably associated to self-medication with a blocker of the renin-angiotensin system.
authors.forename: Fabiana
authors.initials: F
authors.lastname: Esposito
authors.forename: Mariangela
authors.initials: M
authors.lastname: Galfetti
authors.forename: Sebastiano A G
authors.initials: SA
authors.lastname: Lava
authors.forename: Brenno
authors.initials: B
authors.lastname: Balestra
authors.forename: Mario G
authors.initials: MG
authors.lastname: Bianchetti
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000328:Adult; D047228:Angiotensin II Type 1 Receptor Blockers / Q000009:adverse effects* / Q000627:therapeutic use; D000962:Antimalarials / Q000627:therapeutic use; D002585:Cesarean Section; D005260:Female; D005317:Fetal Growth Retardation / Q000139:chemically induced* / Q000175:diagnosis; D006801:Humans; D006886:Hydroxychloroquine / Q000627:therapeutic use; D007231:Infant, Newborn; D007668:Kidney / Q000000981:diagnostic imaging / Q000187:drug effects; D019808:Losartan / Q000009:adverse effects* / Q000627:therapeutic use; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy; D008297:Male; D008790:Metoprolol / Q000627:therapeutic use; D016104:Oligohydramnios / Q000139:chemically induced* / Q000175:diagnosis; D011247:Pregnancy; D012084:Renin-Angiotensin System / Q000187:drug effects*; D012651:Self Medication / Q000009:adverse effects*; D014463:Ultrasonography
chemical_list: D000319:Adrenergic beta-Antagonists; D047228:Angiotensin II Type 1 Receptor Blockers; D000962:Antimalarials; D006886:Hydroxychloroquine; D008790:Metoprolol; D019808:Losartan